252 related articles for article (PubMed ID: 9186879)
1. The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD.
Douma CE; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1997 Jun; 51(6):1885-92. PubMed ID: 9186879
[TBL] [Abstract][Full Text] [Related]
2. Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells.
Douma CE; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1998 Apr; 53(4):1014-21. PubMed ID: 9551412
[TBL] [Abstract][Full Text] [Related]
3. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
Douma CE; de Waart DR; Struijk DG; Krediet RT
Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
[TBL] [Abstract][Full Text] [Related]
4. Are phospholipase A2 and nitric oxide involved in the alterations in peritoneal transport during CAPD peritonitis?
Douma CE; de Waart DR; Struijk DG; Krediet RT
J Lab Clin Med; 1998 Oct; 132(4):329-40. PubMed ID: 9794705
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin inhibition by intraperitoneal indomethacin has no effect on peritoneal permeability during stable CAPD.
Douma CE; de Waart DR; Zemel D; Struijk DG; Krediet RT
Nephrol Dial Transplant; 2001 Apr; 16(4):803-8. PubMed ID: 11274278
[TBL] [Abstract][Full Text] [Related]
6. Substrate and inhibitor for nitric oxide synthase during peritoneal dialysis in rabbits.
Douma CE; Zweers MM; de Waart DR; van der Wardt AB; Krediet RT; Struijk DG
Perit Dial Int; 1999; 19 Suppl 2():S358-64. PubMed ID: 10406547
[TBL] [Abstract][Full Text] [Related]
7. Similarities and differences between the effects of amino acids and nitroprusside on peritoneal permeability during CAPD.
Douma CE; Imholz AL; Struijk DG; Krediet RT
Blood Purif; 1998; 16(2):57-65. PubMed ID: 9572398
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
Smit W; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal transport characteristics with glucose polymer based dialysate.
Ho-dac-Pannekeet MM; Schouten N; Langendijk MJ; Hiralall JK; de Waart DR; Struijk DG; Krediet RT
Kidney Int; 1996 Sep; 50(3):979-86. PubMed ID: 8872974
[TBL] [Abstract][Full Text] [Related]
10. The standard peritoneal permeability analysis in the rabbit: a longitudinal model for peritoneal dialysis.
Zweers MM; Douma CE; de Waart DR; van der Wardt AB; Ho-dac-Pannekeet MM; Krediet RT; Struijk DG
Perit Dial Int; 1999; 19(1):56-64. PubMed ID: 10201342
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of oral route isosorbide 5-mononitrate on peritoneal solute and fluid transports in CAPD patients.
Kanjanabuch T; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S129-37. PubMed ID: 17044464
[TBL] [Abstract][Full Text] [Related]
12. [Effects of nitroprusside and vibration on peritoneal transport of solutes in continuous ambulatory peritoneal dialysis patients].
Tan XY; Liu FY; Duan SB
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):357-60. PubMed ID: 12206001
[TBL] [Abstract][Full Text] [Related]
13. Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD.
Imholz AL; Koomen GC; Struijk DG; Arisz L; Krediet RT
Kidney Int; 1993 Jun; 43(6):1339-46. PubMed ID: 8315948
[TBL] [Abstract][Full Text] [Related]
14. Nitrate in stable CAPD patients and during peritonitis.
Douma CE; de Waart DR; Zemel D; Imholz AL; Koomen GC; Struijk DG; Krediet RT
Adv Perit Dial; 1995; 11():36-40. PubMed ID: 8534733
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations.
Plum J; Fusshöller A; Schoenicke G; Busch T; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
Nephrol Dial Transplant; 1997 Aug; 12(8):1652-60. PubMed ID: 9269644
[TBL] [Abstract][Full Text] [Related]
16. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
[TBL] [Abstract][Full Text] [Related]
17. Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
Zweers MM; de Waart DR; Smit W; Struijk DG; Krediet RT
J Lab Clin Med; 1999 Aug; 134(2):124-32. PubMed ID: 10444025
[TBL] [Abstract][Full Text] [Related]
18. A comparison between 1.36% and 3.86% glucose dialysis solution for the assessment of peritoneal membrane function.
Smit W; Langedijk MJ; Schouten N; van den Berg N; Struijk DG; Krediet RT
Perit Dial Int; 2000; 20(6):734-41. PubMed ID: 11216568
[TBL] [Abstract][Full Text] [Related]
19. Restriction coefficients of low molecular weight solutes and macromolecules during peritoneal dialysis.
Ho-dac-Pannekeet MM; Koopmans JG; Struijk DG; Krediet RT
Adv Perit Dial; 1997; 13():72-6. PubMed ID: 9360654
[TBL] [Abstract][Full Text] [Related]
20. The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients.
Pannekeet MM; Imholz AL; Struijk DG; Koomen GC; Langedijk MJ; Schouten N; de Waart R; Hiralall J; Krediet RT
Kidney Int; 1995 Sep; 48(3):866-75. PubMed ID: 7474677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
